Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Martell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- Francesca Barone - $236K in CADL purchases and sales in the last 12 months
- Seshu Tyagarajan - $154K in CADL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Martell?
Christopher Martell is a corporate insider of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christopher Martell last file a Form 4?
The only primary Form 4 on record is dated 24 June 2026.